Expert Panel Review Further Validates Use of ZORYVE® (roflumilast) Topical Foam, 0.3% for Treatment of Seborrheic Dermatitis Across Diverse Hair Types Published in Journal of Clinical and Aesthetic D
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/11/2026
- Wall Street posts weekly gains with earnings, inflation data on tap
- Oil prices settle higher as more production shut ahead of hurricane
- Apple cuts iPhone 18 Pro orders due to soft demand, Nikkei Asia reports
- UBS flags level in gold prices where dip buyers will likely emerge
- Telecom stocks tumble on SpaceX spectrum acquisition news
| (NASDAQ: ARQT) | Delayed: 26.58 +2.09 (8.53%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $24.49 | 52 Week High | $ | |||
| Open | $24.50 | 52 Week Low | $ | |||
| Day High | $26.97 | P/E | N/A | |||
| Day Low | $24.30 | EPS | $ | |||
| Volume | 1,731,607 | |||||
| (NASDAQ: ARQT) | Delayed: 26.58 +2.09 (8.53%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $24.49 | 52 Week High | $ | |||
| Open | $24.50 | 52 Week Low | $ | |||
| Day High | $26.97 | P/E | N/A | |||
| Day Low | $24.30 | EPS | $ | |||
| Volume | 1,731,607 | |||||
